Gilead Sciences Inc
XHAM:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
XHAM:GIS
|
US |
|
H
|
Hang Lung Group Ltd
HKEX:10
|
HK |
|
I
|
Imas Makina Sanayi AS
IST:IMASM.E
|
TR |
|
Gascoyne Resources Ltd
ASX:GCY
|
AU |
|
M
|
Micronics Japan Co Ltd
TSE:6871
|
JP |
|
S
|
South China Holdings Co Ltd
HKEX:413
|
HK |
|
M
|
Mangoceuticals Inc
NASDAQ:MGRX
|
US |
|
Tintra PLC
LSE:TNT
|
UK |
|
B
|
Bitdeer Technologies Group
NASDAQ:BTDR
|
SG |
|
Modern Dental Group Ltd
HKEX:3600
|
HK |
|
S
|
Seaport Entertainment Group Inc
AMEX:SEG
|
US |
|
Sreeleathers Ltd
NSE:SREEL
|
IN |
|
Darling Ingredients Inc
NYSE:DAR
|
US |
|
H
|
High Tide Resources Corp
CNSX:HTRC
|
CA |
|
Chukyoiyakuhin Co Ltd
TSE:4558
|
JP |
|
Vir Biotechnology Inc
NASDAQ:VIR
|
US |
Bankruptcy Probability
Gilead Sciences Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Gilead Sciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
99B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
27B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Gilead Sciences Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Gilead Sciences Inc has total debt of 22.1B USD. This includes both short-term (0 USD) and long-term (22.1B USD) debt.
You can find a full breakdown on its Balance Sheet.
